SCHEMBL9938210

SCHEMBL9938210

COCCN(C)C(=O)c1cc(C(=O)N(Cc2ccc(-c3ccccc3)cc2)NCC(O)C(=O)O)[nH]n1

nearest known ligand 0.64

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 20/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28023724 0.88 MME (0.51) MME
SCHEMBL27914045 0.87 MME (0.62) MME
SCHEMBL9938214 0.86 MME (0.53) MME
SCHEMBL16458038 0.85 MME (0.51) MME
SCHEMBL16458036 0.85 MME (0.51) MME
SCHEMBL9935742 0.83 MME (0.62) MME
SCHEMBL9935739 0.83 MME (0.62) MME
SCHEMBL27932205 0.82 MME (0.60) MME
SCHEMBL27932188 0.80 MME (0.60) MME
SCHEMBL27913953 0.80 MME (0.58) MME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103261168-B Enkephalinase inhibitor THERAVANCE BIOPHARMA R&D IP, LLC (US) 2015-08-05 — — CN disclosed
EP-2651900-A1 NEPRILYSIN INHIBITORS Theravance, Inc. (US) 2013-10-23 — — EP disclosed
CN-103261168-A Enkephalinase inhibitors THERAVANCE INC 2013-08-21 — — CN disclosed
WO-2012082857-A1 NEPRILYSIN INHIBITORS THERAVANCE, INC. (US) 2012-06-21 — — WO disclosed
Send feedback